No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs561208748 |
chr11:36647355-36647356 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs529927399 |
chr11:36647362-36647363 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs369943145 |
chr11:36647376-36647377 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs141654530 |
chr11:36647410-36647411 |
Weak transcription ZNF genes & repeats Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs543115369 |
chr11:36647456-36647457 |
Weak transcription ZNF genes & repeats Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs376359113 |
chr11:36647458-36647459 |
Weak transcription ZNF genes & repeats Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs151102064 |
chr11:36647513-36647514 |
Weak transcription ZNF genes & repeats Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs538875147 |
chr11:36647522-36647523 |
Weak transcription ZNF genes & repeats Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs533438877 |
chr11:36647537-36647538 |
Weak transcription ZNF genes & repeats Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs187956971 |
chr11:36647589-36647590 |
Weak transcription ZNF genes & repeats Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs571422437 |
chr11:36647591-36647592 |
Weak transcription ZNF genes & repeats Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs371282994 |
chr11:36647592-36647593 |
Weak transcription ZNF genes & repeats Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs141031805 |
chr11:36647615-36647616 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs373449528 |
chr11:36647655-36647656 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs150280033 |
chr11:36647666-36647667 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs536534139 |
chr11:36647726-36647727 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs556862473 |
chr11:36647731-36647732 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs576515153 |
chr11:36647747-36647748 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs113867693 |
chr11:36647754-36647755 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs113657047 |
chr11:36647791-36647792 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs564939945 |
chr11:36647817-36647818 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs572194109 |
chr11:36647839-36647840 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs117722512 |
chr11:36647868-36647869 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs560709446 |
chr11:36647869-36647870 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs529736376 |
chr11:36647878-36647879 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs549805533 |
chr11:36647917-36647918 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs370079700 |
chr11:36647972-36647973 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs563606487 |
chr11:36648000-36648001 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs532139874 |
chr11:36648016-36648017 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs114224298 |
chr11:36648032-36648033 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs192432900 |
chr11:36648040-36648041 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs76982025 |
chr11:36648078-36648079 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs60156568 |
chr11:36648120-36648121 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
34 |
rs549425812 |
chr11:36648122-36648123 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs567548194 |
chr11:36648165-36648166 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs16929212 |
chr11:36648185-36648186 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
37 |
rs139024599 |
chr11:36648225-36648226 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs570345004 |
chr11:36648227-36648228 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs539209148 |
chr11:36648250-36648251 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs559173696 |
chr11:36648272-36648273 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs534976383 |
chr11:36648342-36648343 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs572713989 |
chr11:36648377-36648378 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs541119059 |
chr11:36648398-36648399 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs184415790 |
chr11:36648402-36648403 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs115716460 |
chr11:36648432-36648433 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs140692560 |
chr11:36648446-36648447 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs553391730 |
chr11:36648640-36648641 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs114109410 |
chr11:36648641-36648642 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs532251185 |
chr11:36648649-36648650 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs545723655 |
chr11:36648745-36648746 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|